Women's food supplements: from niche to historic growth driver

The market for women's dietary supplements is expanding at a lightning pace, and has now gone beyond the status of a secondary segment. Its average annual growth of +12% between 2020 and 2024, compared with only +3% for the overall market, illustrates a genuine transformation of the nutraceuticals industry. In 2024, its value is estimated at between USD 57.4 and 66.4 billion, and projections put it at between USD 77.5 and 91.4 billion by 2030. For players in the sector, this is no longer a back-up market, but strategic territory.

Why the boom in women's food supplements?

There are three main factors behind the spectacular growth in women's food supplements:

Scientific innovation Ashwagandha, an adaptogenic star, has a CAGR of +28%; the probiotics Intimates grew by +29%; and inositol, used in the treatment of PCOS, jumped by +56%. These ingredients, backed by solid clinical data, offer targeted solutions to women's specific health problems.
The transformation of uses Gummies: Consumers are demanding practical, effective and pleasant formats. Gummies, which are growing at a rate of +30% per year, are improving therapeutic compliance by +40% compared with traditional capsules.
Liberating speech The menopause, long a taboo subject, is becoming a major focus for innovation. Launches of supplements dedicated to this period of life increased by 45% in 2024, a sign of a market opening up.

👉 Listen to our audio Dive into the key trends in women's food supplements explained by Julia and Nicolas (produced by IA, with real figures).

The fastest-growing segments for women's food supplements

The most dynamic sub-categories reflect the combination of science, consumer expectations and attractive formats:

Ashwagandha - Studies show a reduction of 30% in serum cortisol and up to -87% in menopausal symptoms, with a reference dose of 600 mg/day of KSM-66.
Specialised probiotics - Stumps L. rhamnosus GR-1 and L. reuteri RC-14, administered at 2.5 × 10⁹ CFU/day each, play a crucial role in maintaining optimal vaginal pH and reducing recurrent urinary tract infections and mycoses.
Nutricosmetics - The collagen + biotin duo is attracting a clientele with an eye for beauty-from-within. The global market is expected to reach USD 13 billion by 2032, with innovations combining marine collagen, hyaluronic acid and antioxidant vitamins.
Innovative formats - Gummies stand out for their improved bioavailability and their ability to justify a premium positioning (+35% average price vs capsules).

👉 See the summary in this animated video Discover the facts and figures in 3 minutes.

B2B: a changing ecosystem

The B2B dynamic illustrates the extent to which the value chain is being restructured:

Private label Demand for customisation is exploding. Players such as Vox Nutrition offer more than 115 ready-to-use formulations, while Private Label Express can launch products in as few as 200 bottles, with FDA certification.
Practitioner channel With over 700,000 prescribing doctors in the United States, for example, distribution via healthcare professionals is becoming an essential channel. Digital platforms simplify the management of recommendations and orders. A model that is also true in Europe.
Personalisation via AI DNA analysis, combined with AI algorithms, enables us to offer formulations tailored to genetic profiles. GenoPalate, for example, uses more than 150 markers to create tailor-made nutritional programmes.

High-potential niches

Some niches stand out for their largely untapped potential:

The perimenopause This segment, estimated at USD 9 billion by 2024, Despite playing a central role in the hormonal health of women between the ages of 40 and 50, it remains under-addressed. Unmet needs relate to mood management, energy and sleep.
Generation Z This population represents 30% of wellness-oriented consumers. They are heavy users of social networks (60% say they use them to look for health information), and prefer supplements linked to mental health, stress management and natural beauty.

In conclusion

The women's food supplements market no longer simply exists, it is now dictating new rules for growth. The players capable of combining :

solid scientific evidence (clinically validated ashwagandha, specialised probiotics, 40:1 inositol ratio for PCOS),
a consumer-focused approach (practical formats, a no-holds-barred approach to menopause and perimenopause),
and operational excellence (B2B, private label, AI and applied genomics), will capture a significant share of this booming market. In Europe alone, the outlook is for 12 billion by 2027, confirming a major strategic shift.